Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases
Open Access
- 17 June 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (35) , 57290-57300
Abstract
Background: The phenomenon of chemotherapy-related lipid alterations has been reported based on a small number of patients and varies among different cancers. However, little is known about these alterations in colorectal cancer (CRC) patients.Keywords
This publication has 28 references indexed in Scilit:
- Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinomaOncotarget, 2015
- Atypical plasma lipid profile in cancer patients: Cause or consequence?Biochimie, 2014
- [Analysis and prediction of colorectal cancer incidence trend in China].2012
- HDL Mimetics Inhibit Tumor Development in Both Induced and Spontaneous Mouse Models of Colon CancerMolecular Cancer Therapeutics, 2012
- Evaluation of serum high‐density lipoprotein cholesterol levels as a prognostic factor in gastric cancer patientsJournal of Gastroenterology and Hepatology, 2012
- Baseline and On-Treatment High-Density Lipoprotein Cholesterol and the Risk of Cancer in Randomized Controlled Trials of Lipid-Altering TherapyJACC, 2010
- Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin.2009
- Serum lipoproteins and cancerNutrition, Metabolism and Cardiovascular Diseases, 2009
- Influence of 5-Fluorouracil on Serum LipidsActa Oncologica, 1995
- Changes in serum lipids and lipoproteins in cancer patients during chemotherapyCancer Chemotherapy and Pharmacology, 1992